In a 100% AMR Clinical-run phase II trial for botulism prevention, 14 AMR sites successfully enrolled 250 patients, exceeding expectations with 1+ month accelerated enrollment and 85% alignment to U.S. Census demographics. AMR Clinical’s project delivery model ensured streamlined protocol execution, proactive issue resolution, and strong communication between sites and sponsor teams.
Explore this case study to see how AMR Clinical delivered:
- Rapid enrollment across diverse U.S. populations
- Tight alignment to demographic and protocol targets
- Seamless site coordination across 14 trial locations